1 International Diabetes Federation, “IDF Diabetes Atlas | Global Diabetes Data & Statistics 2021,” accessed July 10, 2025, https://diabetesatlas.org/.
2N. E. Rahim, D. Flood, M. E. Marcus, et al., “Diabetes Risk and Provision of Diabetes Prevention Activities in 44 Low-Income and Middle-Income Countries: A Cross-Sectional Analysis of Nationally Representative, Individual-Level Survey Data,” Lancet Global Health 11 (2023): e1576–e1586, https://doi.org/10.1016/S2214-109X(23)00348-0.
3K. R. Bako, M. Mohammadnezhad, D. Sika-Paotonu, S. Sime, and L. Signal, “Diabetes Cam: An Objective Methodology to Study Diabetes Self-Management,” American Journal of Preventive Medicine 66 (2024): 909–913, https://doi.org/10.1016/j.amepre.2023.12.016.
4E. Topol, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again (Basic Books, 2019).
5J. C. Pickup, M. Ford Holloway, and K. Samsi, “Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives,” Diabetes Care 38 (2015): 544–550, https://doi.org/10.2337/dc14-1855.
6T. T. Ly, J. A. Nicholas, A. Retterath, E. M. Lim, E. A. Davis, and T. W. Jones, “Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes: A Randomized Clinical Trial,” Journal of the American Medical Association 310 (2013): 1240, https://doi.org/10.1001/jama.2013.277818.
7B. C. Bonoto, V. E. De Araújo, I. P. Godói, et al., “Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” JMIR mHealth and uHealth 5 (2017): e4, https://doi.org/10.2196/mhealth.6309.
8R. W. Beck, T. Riddlesworth, K. Ruedy, et al., “Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial,” Journal of the American Medical Association 317 (2017): 371, https://doi.org/10.1001/jama.2016.19975.
9H. Kang, J. M. Lobo, S. Kim, and M.-W. Sohn, “Cost-Related Medication Non-Adherence Among U.S. Adults With Diabetes,” Diabetes Research and Clinical Practice 143 (2018): 24–33, https://doi.org/10.1016/j.diabres.2018.06.016.
10V. A. Adepoju, S. Jamil, M. S. Biswas, and A. A. Chowdhury, “Wearable Technology in the Management of Chronic Diseases: A Growing Concern,” Chronic Diseases and Translational Medicine 11 (2025): 117–121, https://doi.org/10.1002/cdt3.156.
11A. Rajkomar, J. Dean, and I. Kohane, “Machine Learning in Medicine,” New England Journal of Medicine 380 (2019): 1347–1358, https://doi.org/10.1056/NEJMra1814259.
12A. L. Peters, A. J. Ahmann, T. Battelino, et al., “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline,” Journal of Clinical Endocrinology and Metabolism 101 (2016): 3922–3937, https://doi.org/10.1210/jc.2016-2534.
13D. Gardner, B. Saboo, J. Kesavadev, et al., “Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook,” Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders 16 (2025): 349–369, https://doi.org/10.1007/s13300-025-01692-0.
14H. Alzghaibi, “Perspectives of People With Diabetes on AI-Integrated Wearable Devices: Perceived Benefits, Barriers, and Opportunities for Self-Management,” Frontiers in Medicine 12 (2025): 1563003, https://doi.org/10.3389/fmed.2025.1563003.
15C. Farrington, R. Hovorka, and H. R. Murphy, “Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England,” Diabetes Technology & Therapeutics 22 (2020): 404–410, https://doi.org/10.1089/dia.2019.0380.
16M. Marschollek, M. Gietzelt, M. Schulze, M. Kohlmann, B. Song, and K.-H. Wolf, “Wearable Sensors in Healthcare and Sensor-Enhanced Health Information Systems: All Our Tomorrows?,” Healthcare Informatics Research 18 (2012): 97, https://doi.org/10.4258/hir.2012.18.2.97.
17M. M. Baig, H. GholamHosseini, A. A. Moqeem, F. Mirza, and M. Lindén, “A Systematic Review of Wearable Patient Monitoring Systems – Current Challenges and Opportunities for Clinical Adoption,” Journal of Medical Systems 41 (2017): 115, https://doi.org/10.1007/s10916-017-0760-1.
18J. C. Miranda, S. A. Raza, B. Kolawole, et al., “Enhancing Diabetes Care in LMICs: Insights From a Multinational Consensus,” Pakistan Journal of Medical Sciences 39 (2023): 1899–1906, https://doi.org/10.12669/pjms.39.7.8881.
19Y. Derrick Anim, B. Anthony Edward, and T. Rita, “Views of Young People Living With Type 1 Diabetes on Continuous Glucose Monitor Use in Ghana,” Global Journal of Medical and Clinical Case Reports 12 (2025): 127–139, https://doi.org/10.17352/2455-5282.000213.
20J. Li, D. Wei, S. Liu, et al., “Efficiency of an mHealth App and Chest-Wearable Remote Exercise Monitoring Intervention in Patients With Type 2 Diabetes: A Prospective, Multicenter Randomized Controlled Trial,” JMIR mHealth and uHealth 9 (2021): e23338, https://doi.org/10.2196/23338.
21A. D. Walle, A. T. Jemere, B. Tilahun, et al., “Intention to use Wearable Health Devices and Its Predictors Among Diabetes Mellitus Patients in Amhara Region Referral Hospitals, Ethiopia: Using Modified UTAUT-2 Model,” Informatics in Medicine Unlocked 36 (2023): 101157, https://doi.org/10.1016/j.imu.2022.101157.
22H. Rehman, A. K. Kamal, S. Sayani, P. B. Morris, A. T. Merchant, and S. S. Virani, “Using Mobile Health (mHealth) Technology in the Management of Diabetes Mellitus, Physical Inactivity, and Smoking,” Current Atherosclerosis Reports 19 (2017): 16, https://doi.org/10.1007/s11883-017-0650-5.
23G. S. Lim, A. T. Cheong, P. Y. Lee, and M. S. Siti-Maisarah, “Intention of Smartphone Application Usage in Diabetes Self-Management and Its Associated Factors Among Patients With Diabetes: A Cross-Sectional Study,” Malaysian Family Physician 20 (2025): 9, https://doi.org/10.51866/oa.729.
24P. Chen, Y. Shen, Z. Li, X. Sun, X. L. Feng, and E. B. Fisher, “What Factors Predict the Adoption of Type 2 Diabetes Patients to Wearable Activity Trackers—Application of Diffusion of Innovation Theory,” Frontiers in Public Health 9 (2022): 773293, https://doi.org/10.3389/fpubh.2021.773293.
25A. D. Walle, T. A. Ferede, A. A. Shibabaw, et al., “Willingness of Diabetes Mellitus Patients to use mHealth Applications and Its Associated Factors for Self-Care Management in a Low-Income Country: An Input for Digital Health Implementation,” BMJ Health & Care Informatics 30 (2023): e100761, https://doi.org/10.1136/bmjhci-2023-100761.
26A. Wubete Abebe, B. C. Tilahun, Z. A. Mekonnen, and M. D. Tegegne, “Intention to Use Patient Portal and Its Predictors Among Patient With Diabetes in Amhara Region Referral Hospitals, Northwest Ethiopia, 2023: UTAUT-2 Model,” Digital Health 10 (2024): 20552076241277177, https://doi.org/10.1177/20552076241277177.
27A. Y. Alhaddad, H. Aly, H. Gad, et al., “Longitudinal Studies of Wearables in Patients With Diabetes: Key Issues and Solutions,” Sensors 23 (2023): 5003, https://doi.org/10.3390/s23115003.
28Z. Du, F. Zhang, Y. Ge, et al., “Application of Wearable Devices in Diabetes Management,” Health and Metabolism 2 (2025): 7, https://doi.org/10.53941/hm.2025.100007.
29 Smiles Med, “Managing Diabetes With Wearable Technology: Trends for 2025,” 2025, https://smilesmed.com/managing-diabetes-with-wearable-technology-trends-for-2025/.